Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Vemurafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 8 Neoplasms 7 Thyroid Neoplasms 4 Thyroid Cancer, Papillary 4 Neoplasm Metastasis 4 Leukemia, Hairy Cell 4 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Carcinoma, Anaplastic 2 Skin Neoplasms 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Hematologic Neoplasms 2 Glioma 2 Colorectal Neoplasms 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid cancer, follicular 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan syndrome 3 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡